NEUROPATHY IMPAIRMENT AND NUTRITIONAL STATUS WITH EPLONTERSEN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS

被引:0
|
作者
Conceicao, Isabel [1 ]
Wixner, Jonas [2 ]
Berk, John [3 ]
Adams, David [4 ]
Polydefkis, Michael [5 ]
Attarian, Shahram [6 ]
Gillmore, Julian [7 ]
Dyck, P. James [8 ]
Coelho, Teresa [9 ,10 ]
Chen, Jersey [11 ]
Hardy, Elise [11 ]
Kwoh, Jesse [12 ]
Natman, Jonatan [13 ]
Cruz, Marcia Waddington [14 ]
机构
[1] Hosp Santa Maria, Ctr Hosp Univ Lisboa Norte, Lisbon, Portugal
[2] Umea Univ, Umea, Sweden
[3] Boston Univ, Sch Med, Boston, MA USA
[4] Hop Bicetre, Le Kremlin Bicetre, France
[5] Johns Hopkins Univ, Baltimore, MD USA
[6] Ctr Hosp Univ La Timone, Neuromuscular Disorders & ALS Dept, Marseille, France
[7] UCL, Natl Amyloidosis Ctr, London, England
[8] Mayo Clin, Dept Neurol, Rochester, MN USA
[9] Ctr Hosp Univ Santo Antonio, Porto, Portugal
[10] ERN NMD, Paris, France
[11] AstraZeneca, Late Stage Dev Cardiovasc Renal & Metab, BioPharmaceut R&D, Gaithersburg, MD USA
[12] Ionis Pharmaceut Inc, Carlsbad, CA USA
[13] AstraZeneca, Global Evidence, BioPharmaceut Med, Gothenburg, Sweden
[14] Univ Fed Rio de Janeiro, Amyloidosis Ctr, CEPARM, Univ Hosp, Rio De Janeiro, Brazil
关键词
Amyloid; ATTRv; eplontersen; polyneuropathy; transthyretin amyloidosis;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P 319
引用
收藏
页码:S138 / S138
页数:1
相关论文
共 50 条
  • [21] Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis
    Kristen, Arnt, V
    Ajroud-Driss, Senda
    Conceicao, Isabel
    Gorevic, Peter
    Kyriakides, Theodoros
    Obici, Laura
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2019, 9 (01) : 5 - 24
  • [23] SWITCHING FROM INOTERSEN TO EPLONTERSEN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS POLYNEUROPATHY
    Conceicao, Isabel
    Weiler, Markus
    Kowacs, Pedro
    Dasgupta, Noel
    Khella, Sami
    Chao, Chi-Chao
    Attarian, Shahram
    Jung, Shiangtung
    Chen, Jersey
    Schneider, Eugene
    Viney, Nicholas
    Gertz, Morie
    Masri, Ahmad
    Cruz, Marcia Waddington
    Coelho, Teresa
    Berk, John
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S138 - S139
  • [24] Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin Amyloidosis
    Masri, Ahmad
    Maurer, Mathew S.
    Claggett, Brian L.
    Kulac, Ian
    Cruz, Marcia Waddington
    Concei, Isabel
    Weiler, Markus
    Berk, John L.
    Gertz, Morie
    Gillmore, Julian D.
    Rush, Stephen
    Chen, Jersey
    Zhou, Wunan
    Kwoh, Jesse
    Duran, Jason M.
    Tsimikas, Sotirios
    Solomon, Scott D.
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (08) : 973 - 980
  • [25] Impact of Patisiran, an RNAi Therapeutic, on Orthostatic Intolerance in Patients with Hereditary Transthyretin-Mediated Amyloidosis
    Gonzalez-Duarte, Alejandra
    Judge, Daniel P.
    Dispenzieri, Angela
    Lin, Hollis
    Merkel, Madeline
    Wang, Yue
    Polydefkis, Michael
    NEUROLOGY, 2020, 94 (15)
  • [26] HELIOS-A: IMPACT OF VUTRISIRAN ON QUALITY OF LIFE AND FUNCTIONAL STATUS IN HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS
    Ajroud-Driss, Senda
    Berk, John L.
    Adams, David
    Gillmore, Julian
    Lin, Kon-Ping
    Kale, Parag
    Koike, Haruki
    Aldinc, Emre
    Chen, Chongshu
    Vest, John
    Obici, Laura
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 : S40 - S41
  • [27] Impact of Patisiran, an RNAi Therapeutic, on Diarrhea Symptoms in Patients With Hereditary Transthyretin-Mediated Amyloidosis
    Obici, Laura
    Gonzalez-Duarte, Alejandra
    Waddington-Cruz, Marcia
    Lin, Hollis
    Merkel, Madeline
    Wang, Yue
    Ueda, Mitsuharu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1657 - S1657
  • [28] Impact of Patisiran, an RNAi Therapeutic, on Orthostatic Intolerance in Patients with Hereditary Transthyretin-Mediated Amyloidosis
    Judge, Daniel P.
    Gonzalez-Duarte, Alejandra
    Dispenzieri, Angela
    Lin, Hollis
    Merkel, Madeline
    Wang, Yue
    Polydefkis, Michael
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S78 - S78
  • [29] Alnylam Act®: Heterogenous Disease Manifestations of Hereditary Transthyretin-Mediated Amyloidosis
    Malladi, Ruthvik
    Truty, Rebecca
    Winder, Tom
    Dinh, Quinn
    Melanson, Maria
    Agarwal, Sonalee
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S111 - S112
  • [30] Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation
    Schmidt, Hartmut H.
    Wixner, Jonas
    Plante-Bordeneuve, Violaine
    Munoz-Beamud, Francisco
    Llado, Laura
    Gillmore, Julian D.
    Mazzeo, Anna
    Li, Xingyu
    Arum, Seth
    Jay, Patrick Y.
    Adams, David
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (06) : 1646 - 1657